The Role of the Pharmacist in the Care of Patients with Chronic Pain

Murphy, Laura; Ng, Karen; Isaac, Pearl; Swidrovich, Jaris; Zhang, Maria; Sproule, Beth

doi:10.2147/iprp.s248699

Cited by 12 publications

(25 citation statements)

References 44 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is increasing evidence for the involvement of pharmacists in pain teams and pain clinics, 17,18,20,21 but the optimal service models for CNCP clinics are not well described. Building on the available evidence, we designed our new service in a way to further support the organisation in meeting the challenges arising due to increased opioid use and inappropriate prescribing patterns 9 .…”

Section: Discussionmentioning

confidence: 99%

“…(p274) In this setting, SHPA provides examples of emerging services which include the triage of high‐risk patients for review, increased monitoring and follow‐up, and the facilitation of early post‐discharge medication review 17 . Other pharmacist activities in this setting may include pharmaceutical consultation, completion of medication histories, medicine selection and dosing, drug interaction checks, monitoring for adverse drug effects, patient education and empowering self‐management, interprofessional and/or multidisciplinary patient care, and advocacy to reduce stigma 18 …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacist ambulatory pain services for a chronic non‐cancer pain clinic: a descriptive study

Maleki,

Szmerling,

Thiruvasagan

et al. 2023

Pharmacy Practice and Res

View full text Add to dashboard Cite

BackgroundPatients presenting to specialist pain clinics are often prescribed complex and high‐risk analgesic regimens. In this setting, pharmacists can help identify at risk patients and provide valuable clinical input to improve patient outcomes.AimTo evaluate the role of a clinical pharmacist in improving the triage, assessment and management of patients presenting to ambulatory pain clinics.MethodThis descriptive study enrolled patients from two chronic noncancer pain clinics from July to December 2021. A new clinical pharmacist service was devised, which operated as telehealth one day per week. The pharmacist was responsible for accepting referrals, triaging based on clinic criteria and updating them with prescription risk factors, in line with SafeScript's traffic light system. Pharmacist clinical services included completion of medication histories, drug dose interventions and patient education. This project received departmental ethical approval from the Eastern Health Office of Research and Ethics prior to commencement (Approval No: QA21‐068).ResultsThe pharmacist assessed 253 patients and identified prescription risk factors for 68 patients; of which 11 (16%) had received opioids from ≥4 prescribers, 10 (15%) were issued a monitored prescription from ≥4 pharmacies, seven (10%) were on high‐risk drug combinations, 25 (37%) had an Oral Morphine Equivalent Daily Dose (OMEDD) of 50–100 mg, and 26 (38%) with OMEDD >100 mg. The pharmacist completed 67 medication histories and provided 22 accepted drug intervention recommendations to clinic physicians, including seven recommendations for dose adjustments, six to cease a medicine and nine to start a new medicine.ConclusionThe pharmacist incorporated SafeScript in the clinics' triage processes and provided valuable clinical interventions complementing the care provided by the pain physicians and the allied health staff.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Pharmacist ambulatory pain services for a chronic non‐cancer pain clinic: a descriptive study

Maleki,

Szmerling,

Thiruvasagan

et al. 2023

Pharmacy Practice and Res

View full text Add to dashboard Cite

show abstract

“…This is not in agreement with the expected role of pharmacists as part of an interprofessional care team. Pharmacists are part of a collaborative healthcare team in providing clinical services on the current medical condition of patients and associated drug information to patients (21,22). 19,23,24).…”

Section: Discussionmentioning

confidence: 99%

Assessment of patient satisfaction on pharmacy services at Felege Hiwot comprehensive specialized hospital, Bahir Dar, Ethiopia

Yehualaw

Tafere

Demsie

et al. 2022

Preprint

View full text Add to dashboard Cite

Background:Patients have explicit desires for quality services when they visit health institutions. Patient satisfaction is a primary means of measuring the effectiveness of healthcare delivery. However, inadequate discovery of their needs may result in patient dissatisfaction. Patients who are satisfied with pharmaceutical care are likely to adherence, seeking for medical attentions and take medications properly. Providing better access to quality pharmacies is a way to improve patient satisfaction with healthcare services. Study Objective:The study was aimed to assess patient satisfaction on pharmacy services at Felege Hiwot comprehensive specialized hospital. Methods:An institution-based cross sectional study design was conducted at FelegeHiwot comprehensive specialized hospital from May 1, 2021 to October 30, 2021. Data was collected by interview with structured questionnaires. Then data was coded, entered and then analyzed by SPSS version 23. The association between predictors and outcome was measured using bivariate logistic regression. Result:In this study 384 study participants were included. Majority of the participants were males (55.37%, N=227). The over-all satisfaction score of participants of this study was65.37%. In our study clients showed greater satisfaction towards pharmacists’ commitment to correct myths (92%), pharmacists availability (88.78) and cleanliness (87.8%). Multivariate analysis indicted physical restriction[AOR=6:95%; CI95%(2.98, 25.9)] and rural residence[AOR=2.43;95%CI(1.71,9.6)] had significant association with pharmacy service dissatisfaction. Among the quality pharmacy service indicators, counseling on how medications work [AOR=9; 95%CI(1.48,8.85)], keeping to dosage regimen [AOR=7.3; 95CI% 5.49,11.06)], and advice on the current medical condition had greater odds of client dissatisfaction. Conclusion: The findings of the current study showed that patients’ satisfaction towards outpatient pharmacy services provided by FelegeHiwot comprehensive specialized hospital is very low as it is indicated in their perceptions towards revealed written information about medication use, medication availability, medication storage, and instruction about medication side effects.

show abstract

“…The pharmacist's participation in the individualized care of patients shows a positive impact on recovery of their health 22 , and mainly aims at preventing DRPs and improving the pharmacotherapy. Due to the insufficient number of pharmacists for the development of clinical activities, they carry out risk assessments to start monitoring the patients, choosing those at higher risk as a priority for evaluation and evolution in medical charts 23 .…”

Section: Rbfhssmentioning

confidence: 99%

Atuação do farmacêutico clínico no uso de medicamentos por via sondas enterais em terapia intensiva

Mascarenhas¹,

Santana²,

Silva³

et al. 2022

Rev Bras Farm Hosp Serv Saude

View full text Add to dashboard Cite

Objetivo: O objetivo do estudo foi avaliar as intervenções e orientações farmacêuticas relacionadas ao uso de medicamentos por via sondas enterais em Unidade de Terapia Intensiva (UTI). Métodos: Estudo transversal descritivo, oriundo de prontuários de pacientes internados em três UTI de um hospital público do interior da Bahia, onde foram coletadas informações das evoluções farmacêuticas sobre intervenções e orientações de uso de medicamentos via sondas enterais. Resultados: Identificou-se 102 prontuários avaliados por farmacêuticos no período de julho a dezembro de 2019. A maioria dos pacientes eram do sexo masculino (52,5%) e idosos (55,4%). Desses 24,8% tiveram orientações sobre o uso de medicamentos via sondas, 7,8% apresentaram intervenções de contraindicação para o uso de medicamentos via sondas e 9,5% dos pacientes tiveram interações medicamento-dieta descritas em prontuário. A orientação farmacêutica sobre o uso via sondas mais prevalente foi a forma de dissolução dos medicamentos (89,1%), interação medicamentodieta (80%) e pausa da dieta para a administração de medicamentos (75%). A maioria dos medicamentos envolvidos nas orientações/intervenções possuem ação no aparelho cardiovascular (49,3%) e sistema nervoso (20,7%). Conclusão: Verificou-se a relevância da atuação do farmacêutico clínico referente às intervenções e orientações referente ao uso de medicamentos via sondas enterais em pacientes internados em UTI.

show abstract

The Role of the Pharmacist in the Care of Patients with Chronic Pain

Cited by 12 publications

References 44 publications

Pharmacist ambulatory pain services for a chronic non‐cancer pain clinic: a descriptive study

Pharmacist ambulatory pain services for a chronic non‐cancer pain clinic: a descriptive study

Assessment of patient satisfaction on pharmacy services at Felege Hiwot comprehensive specialized hospital, Bahir Dar, Ethiopia

Atuação do farmacêutico clínico no uso de medicamentos por via sondas enterais em terapia intensiva

Contact Info

Product

Resources

About